Physician

Alexander Pearson

According to 2025 Medicare claims, Alexander Pearson (NPI: 1134448665) practices hematology/oncology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is THE UNIVERSITY OF CHICAGO MEDICAL CENTER (NPI: 1033218128; TIN: 36-3488183) and primary practice location at 60637-1447. Pearson is affiliated with the UCMCNACO, LLC (ACO ID: A3531), participating under the MSSP model.

Pearson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 90 traditional Medicare patients, billed 297 HCPCS/CPT codes, and received $22,577 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 71 prescription claims across 26 beneficiaries totaling $191,604 in drug costs, led by Levothyroxine Sodium (Levothyroxine Sodium). 2023 DME data shows 51 claims. Open Payments data shows 2 records totaling $264,205. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $12,585 and ending at $191,604. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	30	73	$6,913
2018	46	98	$7,165
2019	116	335	$28,083
2020	117	424	$40,561
2021	90	308	$33,964
2022	78	220	$21,844
2023	97	237	$21,142
2024	90	297	$22,577

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	17	48	$12,585
2016	23	74	$72,285
2017	20	47	$8,593
2018	23	93	$7,017
2019	41	151	$31,299
2020	38	164	$40,733
2021	38	143	$27,277
2022	31	87	$29,883
2023	35	81	$363,929
2024	26	71	$191,604

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	43	$3,762
2020	N/R	63	$6,298
2021	N/R	96	$12,442
2022	N/R	40	$7,035
2023	N/R	51	$12,761
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	16	16	$151
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	30	64	$118
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	42	72	$74
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	19	27	$50
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	27	62	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Levothyroxine Sodium	Levothyroxine Sodium	18	1,440	$296
Gabapentin	Gabapentin	14	840	$248

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	0	$0	N/R
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$264,205	Merck Sharp & Dohme LLC
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alexander Pearson?

Tedicare shows public-source Medicare data for Alexander Pearson (NPI 1134448665), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexander Pearson have ACO affiliation data?

Alexander Pearson is shown with ACO affiliation data for UCMCNACO, LLC (MSSP, ACO ID A3531).

What billing organization is linked to Alexander Pearson?

Alexander Pearson is linked to THE UNIVERSITY OF CHICAGO MEDICAL CENTER (billing NPI 1033218128) in the available physician profile data.

Does Alexander Pearson have Open Payments data?

Alexander Pearson has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.